Security record · archived quarter
PEN
Penumbra, Inc. · Healthcare · Medical - Devices
1Tracked holders
0Δ holders
4.65KShares held
$1.48MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 4.65K | $1.48M | n/a | n/a |
| Q2 2026 | 116 | -12 | 22.38M | $7.07B | +3 | −14 |
| Q1 2026 | 130 | +2 | 22.22M | $7.29B | +14 | −13 |
| Q4 2025 | 129 | +2 | 30.57M | $9.51B | +3 | n/a |
| Q3 2025 | 22 | -2 | 23.38M | $5.92B | n/a | −3 |
| Q2 2025 | 22 | +3 | 20.19M | $5.18B | +3 | n/a |
| Q1 2025 | 16 | 0 | 6.15M | $1.64B | +1 | −1 |
| Q4 2024 | 16 | +2 | 5.72M | $1.36B | +2 | n/a |
| Q3 2024 | 13 | -1 | 4.72M | $917.01M | n/a | −1 |
| Q2 2024 | 14 | n/a | 5.82M | $1.05B | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 4.65K | -23.4% | $1.48M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 479 holders, 33.44M shares, $10.70B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Aug 13
SC 13G: BARCLAYS PLC
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API